Clinical Trial Update: Anti-VEGF Treatment for Prevention of PDR/DME [Phase 3]

View source ↗

Summary

Phase 3 trial update for an anti-VEGF treatment aimed at preventing proliferative diabetic retinopathy and diabetic macular edema; study completed with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema
• Diabetic Retinopathy

Drugs mentioned

• Anti-VEGF treatment

Snippet

Sponsor: Jaeb Center for Health Research | Conditions: Diabetic Retinopathy, Diabetic Macular Edema | Phase 3 | Status: COMPLETED | Results posted: 2021-11-24